• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Crude Oil Up 1%; Verizon Earnings Beat Views

    7/25/23 2:31:00 PM ET
    $BFRG
    $BLPH
    $HGEN
    $INPX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $BFRG alert in real time by email

    U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday.

    The Dow traded up 0.28% to 35,510.96 while the NASDAQ rose 0.91% to 14,187.05. The S&P 500, also rose, gaining, 0.48% to 4,576.60.

    Check This Out: Galectin Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying

     

    Leading and Lagging Sectors

    • Materials shares climbed by 1.8% on Tuesday.
    • In trading on Tuesday, real estate shares fell by 0.6%.

     

    Top Headline

    Verizon Communications Inc (NYSE:VZ) reported better-than-expected earnings for its second quarter.

    It clocked a sales decline of 3.5% year-on-year to $32.6 billion, missing the consensus of $33.3 billion. Adjusted EPS of $1.21 beat the consensus of $1.16.

     

    Equities Trading UP

    • Inpixon (NASDAQ:INPX) shares shot up 87% to $0.2848 after the company agreed to merge with XTI Aircraft Company.
    • Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) got a boost, shooting 32% to $19.77 following strong quarterly results.
    • Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) shares were also up, gaining 34% to $4.63 after the company announced US patent for novel prodrugs of mebendazole and their use in treating cancer.

     

    Equities Trading DOWN

    • Humanigen, Inc. (NASDAQ:HGEN) shares dropped 76% to $0.0464. Humanigen said it anticipates that it will not be able to continue as a going concern and is exploring all restructuring options, including bankruptcy.
    • Shares of Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) were down 39% to $0.4349 after the company received a delisting notice.
    • Stoke Therapeutics, Inc. (NASDAQ:STOK) was down, falling 33% to $ 6.36 after the company announced new safety and efficacy data from STK-001 in the two ongoing Phase 1/2a studies and the SWALLOWTAIL open-label extension study in children and adolescents with Dravet syndrome.

    Also Check This Out: Top 4 Tech & Telecom Stocks That May Rocket Higher In July

     

    Commodities

    In commodity news, oil traded up 1% to $79.52 while gold traded up 0.1% at $1,963.40.

    Silver traded up 1% to $24.82 on Tuesday while copper rose 1.5% to $3.9140.

     

    Euro zone

    European shares were mostly higher today. The eurozone’s STOXX 600 rose 0.48%, London’s FTSE 100 rose 0.17% while Spain’s IBEX 35 Index fell 0.25% The German DAX rose 0.13% French CAC 40 fell 0.16% and Italy’s FTSE MIB Index rose 0.2%.

    The Ifo Business Climate indicator for Germany declined for the third straight month to 87.3 in July. The CBI's quarterly gauge of manufacturing optimism in the UK rose to +6 in the third quarter compared to -2.0 in the prior three-month period.

     

    Asia Pacific Markets

    Asian markets closed mixed on Tuesday, with Japan’s Nikkei 225 falling 0.06%, China’s Shanghai Composite Index gaining 2.13% and Hong Kong’s Hang Seng Index gaining 4.10%. India’s S&P BSE Sensex, meanwhile, fell 0.04%.

    Exports from Hong Kong declined 11.4% year-over-year to $337.4 billion in June, while imports to Hong Kong fell 12.3% year-over-year to $393.9 billion.

     

    Economics

    • The S&P CoreLogic Case-Shiller 20-city home price index declined 1.7% year-over-year in May, the same as in April.
    • The FHFA house price index increased by 0.7% versus the previous month in May.
    • The Manufacturing Activity Index in the Richmond area fell to -9 in July from -8 in June.

    Now Read This: These Analysts Cut Their Forecasts On CSX After Q2 Results

     

    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 107,478,000 cases with around 1,169,620 deaths. India confirmed a total of at least 44,995,310 cases and 531,910 deaths, while France reported over 40,138,560 COVID-19 cases with 167,640 deaths. In total, there were at least 692,123,800 cases of COVID-19 worldwide with more than 6,902,510 deaths.

    Get the next $BFRG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BFRG
    $BLPH
    $HGEN
    $INPX

    CompanyDatePrice TargetRatingAnalyst
    Kiniksa Pharmaceuticals International plc
    $KNSA
    2/19/2026$62.00Buy
    Canaccord Genuity
    Verizon Communications Inc.
    $VZ
    2/19/2026$58.00Outperform → Buy
    Daiwa Securities
    Stoke Therapeutics Inc.
    $STOK
    2/5/2026$60.00Buy
    Guggenheim
    Verizon Communications Inc.
    $VZ
    1/22/2026$43.00Equal Weight
    Barclays
    Stoke Therapeutics Inc.
    $STOK
    1/5/2026$35.00Buy
    Chardan Capital Markets
    Verizon Communications Inc.
    $VZ
    10/21/2025$44.00Outperform → Neutral
    BNP Paribas Exane
    Kiniksa Pharmaceuticals International plc
    $KNSA
    9/29/2025$60.00Buy
    TD Cowen
    Verizon Communications Inc.
    $VZ
    9/2/2025$49.00Buy
    Goldman
    More analyst ratings

    $BFRG
    $BLPH
    $HGEN
    $INPX
    SEC Filings

    View All

    SEC Form FWP filed by Verizon Communications Inc.

    FWP - VERIZON COMMUNICATIONS INC (0000732712) (Subject)

    2/18/26 4:25:44 PM ET
    $VZ
    Telecommunications Equipment
    Public Utilities

    SEC Form FWP filed by Verizon Communications Inc.

    FWP - VERIZON COMMUNICATIONS INC (0000732712) (Subject)

    2/18/26 4:23:03 PM ET
    $VZ
    Telecommunications Equipment
    Public Utilities

    Bullfrog AI Holdings Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

    8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer)

    2/17/26 4:30:37 PM ET
    $BFRG
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BFRG
    $BLPH
    $HGEN
    $INPX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by CHIEF MEDICAL OFFICER Ticho Barry

    4 - Stoke Therapeutics, Inc. (0001623526) (Issuer)

    2/19/26 4:25:56 PM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Chief Executive Officer Smith Ian F

    4 - Stoke Therapeutics, Inc. (0001623526) (Issuer)

    2/19/26 4:24:03 PM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Chief Financial Officer Leggett Thomas

    4 - Stoke Therapeutics, Inc. (0001623526) (Issuer)

    2/19/26 4:22:34 PM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BFRG
    $BLPH
    $HGEN
    $INPX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

    LONDON, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) announced today that it will host a conference call and live webcast on Tuesday, February 24, 2026 at 8:30 a.m. Eastern Time to report its fourth quarter and full year 2025 financial results and recent portfolio execution. A live webcast will be accessible through the Investors & Media section of the company's website at www.kiniksa.com. Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique p

    2/19/26 4:01:00 PM ET
    $KNSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

    Stoke Therapeutics, Inc. (NASDAQ:STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on February 17, 2026, it granted stock options to purchase an aggregate of 22,950 shares of common stock to five new employees, as a material inducement to their employment in accordance with Nasdaq Listing Rule 5635(c)(4). The stock options that were granted have an exercise price of $31.09 per share, which is equal to the closing price of

    2/18/26 4:01:00 PM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Verizon to speak at Barclays Communications and Content Symposium on February 24

    NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tony Skiadas, executive vice president and chief financial officer at Verizon ((NYSE, NASDAQ:VZ), is scheduled to speak at the Barclays Communications and Content Symposium on Tuesday, February 24, at 8:00 a.m. ET. The session will be webcast, with access instructions available on Verizon's Investor Relations website, www.verizon.com/about/investors. Verizon Communications Inc. ((NYSE, NASDAQ:VZ) powers and empowers how its millions of customers live, work and play, delivering on their demand for mobility, reliable network connectivity and security. Headquartered in New York City, serving countries worldwide and nearly all of the Fortune 500, Ve

    2/18/26 9:00:00 AM ET
    $VZ
    Telecommunications Equipment
    Public Utilities

    $BFRG
    $BLPH
    $HGEN
    $INPX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Kiniksa Pharmaceuticals with a new price target

    Canaccord Genuity initiated coverage of Kiniksa Pharmaceuticals with a rating of Buy and set a new price target of $62.00

    2/19/26 7:51:41 AM ET
    $KNSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Verizon upgraded by Daiwa Securities with a new price target

    Daiwa Securities upgraded Verizon from Outperform to Buy and set a new price target of $58.00

    2/19/26 7:49:11 AM ET
    $VZ
    Telecommunications Equipment
    Public Utilities

    Guggenheim initiated coverage on Stoke Therapeutics with a new price target

    Guggenheim initiated coverage of Stoke Therapeutics with a rating of Buy and set a new price target of $60.00

    2/5/26 6:58:02 AM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BFRG
    $BLPH
    $HGEN
    $INPX
    Financials

    Live finance-specific insights

    View All

    Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

    LONDON, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) announced today that it will host a conference call and live webcast on Tuesday, February 24, 2026 at 8:30 a.m. Eastern Time to report its fourth quarter and full year 2025 financial results and recent portfolio execution. A live webcast will be accessible through the Investors & Media section of the company's website at www.kiniksa.com. Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique p

    2/19/26 4:01:00 PM ET
    $KNSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Verizon Delivers on 2025 Financial Guidance with Highest Quarterly Net Adds Since 2019

    Strong Fourth-Quarter Results and 2026 Guidance Reflect Impact of Bold Actions and Beginning of Verizon's Turnaround  Key Highlights: More than 1 million total net additions across mobility and broadband, highest reported quarterly net additions since 2019, with 616,000 postpaid phone net additionsFrontier acquisition expands fiber access to over 30 million homes and businesses, accelerating national mobility and broadband convergence strategy NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Verizon Communications Inc. ((NYSE, NASDAQ:VZ) today reported fourth-quarter and full-year 2025 results, marking a critical inflection point for the company. Driven by a play to win mandate from CEO Da

    1/30/26 6:30:00 AM ET
    $VZ
    Telecommunications Equipment
    Public Utilities

    Verizon declares quarterly dividend on December 4

    NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- The Board of Directors at Verizon Communications Inc. ((NYSE, NASDAQ:VZ) today declared a quarterly dividend of 69 cents per outstanding share, consistent with the prior quarter's dividend rate. The quarterly dividend is payable on February 2, 2026 to Verizon shareholders of record at the close of business on January 12, 2026. "Verizon is transforming to be a leaner, faster and bolder team focused on delighting customers to regain market leadership," said Dan Schulman, CEO of Verizon. "We are committed to delivering increasing value for our shareholders and the dividend is an iron clad reflection of that commitment. Our 19 consecutive years of d

    12/4/25 1:31:51 PM ET
    $VZ
    Telecommunications Equipment
    Public Utilities

    $BFRG
    $BLPH
    $HGEN
    $INPX
    Leadership Updates

    Live Leadership Updates

    View All

    StandardAero Set to Join S&P MidCap 400

    NEW YORK, Jan. 16, 2026 /PRNewswire/ -- StandardAero Inc. (NYSE:SARO) will replace Frontier Communications Parent Inc. (NASD: FYBR) in the S&P MidCap 400 effective prior to the opening of trading on Thursday, January 22. S&P 500 & S&P 100 constituent Verizon Communications Inc. (NYSE:VZ) is acquiring Frontier Communications Parent in a deal expected to close soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector Jan 22, 2026 S&P MidCap 400 Addition StandardAero SARO Industrials Jan 22, 2026 S&P MidCap 400 Deletion Frontier Communicati

    1/16/26 6:26:00 PM ET
    $FYBR
    $SARO
    $SPGI
    Telecommunications Equipment
    Telecommunications
    Aerospace
    Industrials

    Verizon Business powers KPMG's new Manhattan headquarters with Neutral Host Network

    NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Verizon Business today announced that it has equipped the new U.S. headquarters of KPMG LLP, the U.S. audit, tax and advisory firm, with a dedicated network powered by Verizon 5G. Located at Two Manhattan West in New York City, the office's Neutral Host Network solution will leverage Verizon's advanced 5G technology and infrastructure to deliver a seamless and reliable wireless experience—across carriers—for KPMG clients and employees alike. "Our new headquarters at Two Manhattan West is designed to deliver a first-class, tech-enabled experience for our people and clients, and Verizon Business is the trusted partner helping us bring that vision

    11/5/25 10:00:00 AM ET
    $VZ
    Telecommunications Equipment
    Public Utilities

    Verizon Announces CEO Transition

    Board of Directors Appoints Independent Lead Director and Former CEO of PayPal, Dan Schulman, as Chief Executive Officer Hans Vestberg to Serve as Special Advisor Through October 4, 2026 and Member of the Board of Directors until the 2026 Annual Meeting Mark Bertolini Appointed Chairman of the Board of Directors Company Reiterates Full-Year 2025 Financial Guidance NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Verizon Communications Inc. ((NYSE, NASDAQ:VZ) today announced that its Board of Directors has appointed Independent Lead Director and former Chief Executive Officer of PayPal Holdings Inc. Dan Schulman as Chief Executive Officer, effective immediately. Mark Bertolini has be

    10/6/25 8:30:00 AM ET
    $VZ
    Telecommunications Equipment
    Public Utilities

    $BFRG
    $BLPH
    $HGEN
    $INPX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Stoke Therapeutics Inc.

    SC 13G/A - Stoke Therapeutics, Inc. (0001623526) (Subject)

    11/14/24 9:00:58 PM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Kiniksa Pharmaceuticals International plc

    SC 13G/A - Kiniksa Pharmaceuticals International, plc (0001730430) (Subject)

    11/14/24 4:32:31 PM ET
    $KNSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Stoke Therapeutics Inc.

    SC 13G - Stoke Therapeutics, Inc. (0001623526) (Subject)

    11/14/24 4:24:49 PM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care